On (b)(6) 2018, an email was received from an eye care professional (ecp).The email contained an attached summary data spreadsheet containing the medical information for subjects involved in the study of acanthamoeba keratitis conducted in the uk.The information received from the ecp included only those study subjects who reported wearing acuvue brand products at the time of the adverse event.All the study subjects were initially examined and diagnosed with acanthamoeba keratitis during 2011-2014.The patient (pt), (b)(6), initially diagnosed with herpes simplex virus keratitis (hsv).The pt was referred to the hospital on (b)(6) 2013 and was diagnosed with acanthamoeba keratitis od.Pt reported wearing the acuvue advance brand contact lenses and used an unknown solution brand.Pt reported lasik 20 years prior.Pt reported the contact lens case was 1 year old, rinsed with water and pt showered in lenses.Pt was treated with antiamoebics 8 months, topical steroid after diagnosis; mycophenolate, iatraconazole.Va: hand motion.No additional information is expected to be received.The lot number of the suspect product is unknown.Suspect product is not available for return for evaluation.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|